The Future of Inducement Claims in the Hatch-Waxman Context: Reconciling the Demarcation Between Describing and Infringing Use and Encouraging That Use in a Label

Location

InterContinental New York Times Square

300 W 44th St.

New York, NY 10036


Date & Time

Start Date: 04/26/2022
End Date: 04/27/2022

 

Aaron Lukas will be moderating at the Paragraph IV Disputes Conference on whether a skinny label alone is enough to preclude induced infringement allegations. Aaron and the panel will also discuss the anticipation of the impact of recent decisions on claim drafting and the availability of generic drugs, devising strategic considerations of label language for inducement infringement, reviewing the approval of generic drug labeling, and assessing the flurry of follow-on cases in the courts.


Sponsor


Attorneys

Aaron Lukas, Ph.D.

Co-Chair, Hatch-Waxman & Biologics Litigation

alukas@cozen.com

(202) 912-4823

Related Practices